Adult Non Hodgkin's Lymphoma Patients: Experience from a Tertiary Care Cancer Centre in North East India |
Hazarika, Munlima
(Department of Medical Oncology, Dr. B Borooah Cancer Institute)
Iqbal, Asif (Department of Medical Oncology, Dr. B Borooah Cancer Institute) Krishnatreya, Manigreeva (Department of Cancer Epidemiology and Biostatistics, Dr. B Borooah Cancer Institute) Sharma, Jagannath Dev (Department of Pathology, Dr. B Borooah Cancer Institute) Bhuyan, Chidananda (Department of Medical Oncology, Dr. B Borooah Cancer Institute) Saikia, Bhargab Jyoti (Department of Medical Oncology, Dr. B Borooah Cancer Institute) Roy, Partha Sarathi (Department of Medical Oncology, Dr. B Borooah Cancer Institute) Das, Rashmi (Department of Medical Oncology, Dr. B Borooah Cancer Institute) Nandy, Pintu (Department of Cancer Epidemiology and Biostatistics, Dr. B Borooah Cancer Institute) Kataki, Amal Chandra (Department of Gynecologic Oncology, Dr. B Borooah Cancer Institute) |
1 | Anderson JR, Armitage JO, Weisenburger DD (1998). Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol, 9, 717-20. DOI |
2 | Balasubramanium G, Saoba S, Sarade M, Pinjare S (2013). Case-control study of risk factors for non-Hodgkin lymphoma in Mumbai, India. Asian Pac J Cancer Prev, 14, 775-80. DOI ScienceOn |
3 | Bofetta P (2011). Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol, 22, 27-31. DOI |
4 | Dominik D. Alexander, Pamela J, et al (2007). The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer, 120, 1-39. |
5 | Elis A, Blickstein B, Klein O, et al (2002). Detection of relapse in non- Hodgkin's lymphoma : role of routine follow up studies. Am J Hematol, 69, 41-4. DOI |
6 | Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. DOI |
7 | Hussain MA, Pati S, Swain S , et al (2012). Pattern and trends of cancer in Odisha, India: a retrospective study. Asian Pac J Cancer Prev, 13, 6333-36. DOI ScienceOn |
8 | Mertsoylu H, Muallaoglu S, Besen AA, et al (2014). Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey. Asian Pac J Cancer Prev, 15, 7207-11. DOI |
9 | Naresh KN, Srinivas V, Soman CS (2000). Distribution of various subtypes of non-Hodgkin's lymphoma in India: astudy of 2773 lymphomas using REAL and WHO Classifications. Ann Oncol, 11, 63-7. |
10 | Padhi S, Paul TR, Challa S, et al (2012). Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev, 13, 4889-95. DOI ScienceOn |
11 | Sader-Ghorra C, Rassy M, Naderi S, Kourie HR, Kattan J (2014). Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev, 15, 5825-8. DOI |
12 | SallesG,Shipp MA, Coiffier B (1994). Chemotherapy of non-Hodgkin's aggressive lymphomza. Semi Hematol, 31, 46-69. |
13 | Schuetz JM, Daley D, Leach S, et al (2013). Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One, 8, 75170. DOI |
14 | Sengar M, Akhade A, Nair R, et al (2011). A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol, 32, 197-203 DOI |
15 | Smedby KE (2006). Epidemiology and etiology of non-Hodgkin lymphoma a review. Acta Oncol, 45, 258-71 DOI |
16 | Zhou JY, He LW, Liu J, et al (2014). Comprehensive assessment of associations between ercc2 lys751gln/asp312asn polymorphisms and risk of non-Hodgkin lymphoma. Asian Pac J Cancer Prev, 15, 9347-53. DOI |
17 | Zelenetz AD, Abramson JS, Advani RJ et al (2011). Non Hodgkin's lymphomas. J Natl Compr Canc Netw, 9, 484-560 |
![]() |